Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients

Abstract

These results strongly suggest that hypoxic MSCs are intrinsically immunoprivileged and can serve as a 'universal donor cell' for treating cardiovascular diseases.